http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015202725-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b6833622f033dca31d5e4c5d49ba0c4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
| filingDate | 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec38926bd24e807b0ba1ba6ad613a686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dbfbbfcfc2064d3b0d7e9da093aa1af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e09b7f21ebede958ef68db9a165107f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e958743a91265fcca9b714ae4a70b286 |
| publicationDate | 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2015202725-A1 |
| titleOfInvention | Neural modulation devices and methods |
| abstract | A system for treating a gastrointestinal disorder or a condition associated with excess weight of a subject comprises: at least one electrode configured to be implanted within a body of the patient and placed at a vagus nerve, the electrode also configured to apply therapy to the 5 vagus nerve upon application of a therapy cycle to the electrode; and an implantable neuroregulator for placement in the body of the patient beneath the skin layer, the implantable neuroregulator being configured to generate a therapy cycle, wherein each therapy cycle comprises: a) a burst of electrical signals having a frequency of at least 1000 Hz, wherein the burst of electrical signals comprises one or more pulses that have a pulse 10 width of about 0.01 milliseconds to about 0.09 milliseconds, a current of about 0.1 to 20 mAmps, wherein each burst is at least 26 milliseconds and includes a delay period between each burst; wherein the burst of electrical signal downregulates activity on the nerve; b ) an on period of at least 2 minutes; c) an off period, wherein the off period is selected to allow at least partial recovery of nerve activity; and d ) a total charge of about 10 to 50,000 15 microcoulombs per therapy cycle. 6479886_1 (GHMatters) P92108.AU.1 SARAHVV 20/05/2015 wL w U)) > mL U') z z zZ ZI > > > 0 Q) |
| priorityDate | 2010-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 352.